DOCTEUR TIMSONET ROXANE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DOCTEUR TIMSONET ROXANE
Largest movements
- Cash +€32,850
up €32,850 (+67.6%), from €48,568 to €81,418
mainly Net result for the year (+€55,385) and Receivables within one year (+€2,122)
- Deferred charges and accrued income +€13,426
up €13,426 (+1,186%), from €1,132 to €14,558
- Current investments +€12,000
up €12,000 (+120%), from €10,000 to €22,000
- Receivables within one year -€2,122
down €2,122 (-9.7%), from €21,835 to €19,713
of which Trade receivables: -€5,813
- Profit (loss) carried forward +€55,386
up €55,386 (+75.7%), from €73,183 to €128,569
- Tax, wage and social debts -€1,974
down €1,974 (-100%), from €1,974 to €0
- Trade debts +€1,678
up €1,678 (+40.4%), from €4,159 to €5,837
- Gross operating margin -€23,364
down €23,364 (-25.0%), from €93,434 to €70,070
- Taxes -€5,666
down €5,666 (-28.4%), from €19,974 to €14,308
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €82,316 | €137,750 | +€55,434 | +67.3% |
| Fixed assets | 21/28 | €781 | €62 | -€719 | -92.1% |
| Tangible fixed assets | 22/27 | €719 | €0 | -€719 | -100% |
| Assets under construction and advance payments | 27 | €719 | €0 | -€719 | -100% |
| Financial fixed assets | 28 | €62 | €62 | -€0 | -0.5% |
| Current assets | 29/58 | €81,535 | €137,689 | +€56,154 | +68.9% |
| Amounts receivable within one year | 40/41 | €21,835 | €19,713 | -€2,122 | -9.7% |
| Trade receivables | 40 | €21,835 | €16,022 | -€5,813 | -26.6% |
| Other amounts receivable | 41 | - | €3,692 | +€3,692 | |
| Current investments | 50/53 | €10,000 | €22,000 | +€12,000 | +120% |
| Cash at bank and in hand | 54/58 | €48,568 | €81,418 | +€32,850 | +67.6% |
| Deferred charges and accrued income | 490/1 | €1,132 | €14,558 | +€13,426 | +1,186% |
| Total equity and liabilities | 10/49 | €82,316 | €137,750 | +€55,434 | +67.3% |
| Equity | 10/15 | €76,183 | €131,569 | +€55,386 | +72.7% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €73,183 | €128,569 | +€55,386 | +75.7% |
| Amounts payable | 17/49 | €6,133 | €6,182 | +€49 | +0.8% |
| Amounts payable within one year | 42/48 | €6,133 | €6,182 | +€49 | +0.8% |
| Trade debts | 44 | €4,159 | €5,837 | +€1,678 | +40.4% |
| Suppliers | 440/4 | €4,159 | €5,837 | +€1,678 | +40.4% |
| Taxes, remuneration and social security | 45 | €1,974 | €0 | -€1,974 | -100% |
| Taxes | 450/3 | €1,974 | €0 | -€1,974 | -100% |
| Other amounts payable | 47/48 | - | €344 | +€344 | |
| Other operating charges | 640/8 | €277 | €378 | +€101 | +36.4% |
| Gross operating margin | 9900 | €93,434 | €70,070 | -€23,364 | -25.0% |
| Operating profit (loss) | 9901 | €93,157 | €69,693 | -€23,464 | -25.2% |
| Financial income | 75/76B | - | €203 | +€203 | |
| Recurring financial income | 75 | - | €203 | +€203 | |
| Financial charges | 65/66B | - | €201 | +€201 | |
| Recurring financial charges | 65 | - | €201 | +€201 | |
| Profit (loss) for the period before taxes | 9903 | €93,157 | €69,694 | -€23,463 | -25.2% |
| Income taxes | 67/77 | €19,974 | €14,308 | -€5,666 | -28.4% |
| Profit (loss) for the period | 9904 | €73,183 | €55,385 | -€17,798 | -24.3% |
| Profit (loss) for the period to be appropriated | 9905 | €73,183 | €55,385 | -€17,798 | -24.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.